BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price -1.05% -11.42% 6.87% 5.14% 32.34% -10.57% -0.28% -0.62% 15.27% 04/07/2010
BIB NAV -1.07% -11.28% 7.10% 5.20% 32.66% -10.45% -0.23% -0.54% 15.28% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.14%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 12/27/2024
  • NAV
    $51.73
  • NAV Change
    $-1.11 down caret
  • Market Price
    $51.83
  • Market Price Change
    $-0.94 down caret
  • Trading Volume (M)
    5,044
  • 30-Day Median Bid Ask Spread
    0.29%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.14%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 12/27/2024
  • NAV
    $51.73
  • NAV Change
    $-1.11 down caret
  • Market Price
    $51.83
  • Market Price Change
    $-0.94 down caret
  • Trading Volume (M)
    5,044
  • 30-Day Median Bid Ask Spread
    0.29%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 9/30/2024

Holdings

as of 12/27/2024

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
6.71% GILD GILEAD SCIENCES INC -- $4,165,873.26 44,266 2369174
6.13% AMGN AMGEN INC -- $3,805,535.85 14,489 2023607
5.87% REGN REGENERON PHARMACEUTICALS -- $3,646,063.20 5,118 2730190
5.76% VRTX VERTEX PHARMACEUTICALS INC -- $3,578,285.04 8,754 2931034
2.94% AZN ASTRAZENECA PLC-SPONS ADR -- $1,827,914.62 27,587 2989044
2.34% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,453,996.70 6,110 B00FWN1
1.68% BIIB BIOGEN INC -- $1,044,039.00 6,900 2455965
1.64% ILMN ILLUMINA INC -- $1,016,012.97 7,511 2613990
1.54% ARGX ARGENX SE - ADR -- $955,749.06 1,526 BDVLM39
1.23% UTHR UNITED THERAPEUTICS CORP -- $761,315.40 2,115 2430412
1.18% MRNA MODERNA INC -- $731,650.16 18,232 BGSXTS3
1.14% VTRS VIATRIS INC -- $705,569.28 56,536 BMWS3X9
1.12% SNY SANOFI-ADR -- $694,987.26 14,262 2964557
1.08% NBIX NEUROCRINE BIOSCIENCES INC -- $668,754.24 4,796 2623911
1.02% SMMT SUMMIT THERAPEUTICS INC -- $636,093.51 34,931 BMTVQS7
1.02% INCY INCYTE CORP -- $631,723.75 9,125 2471950
0.97% BMRN BIOMARIN PHARMACEUTICAL INC -- $603,816.03 9,027 2437071
0.95% INSM INSMED INC -- $589,875.14 8,474 2614487
0.89% SRPT SAREPTA THERAPEUTICS INC -- $549,787.50 4,525 B8DPDT7
0.87% RPRX ROYALTY PHARMA PLC- CL A -- $537,438.22 21,043 BMVP7Y0
0.85% BNTX BIONTECH SE-ADR -- $530,095.40 4,652 BK6H543
0.81% MEDP MEDPACE HOLDINGS INC -- $502,128.64 1,472 BDCBC61
0.77% PCVX VAXCYTE INC -- $478,046.88 5,904 BKPVGH6
0.74% EXEL EXELIXIS INC -- $457,314.06 13,526 2576941
0.69% ITCI INTRA-CELLULAR THERAPIES INC -- $425,947.00 5,020 BHCB0P4
0.66% ROIV ROIVANT SCIENCES LTD -- $406,875.80 34,481 BMW4NZ9
0.63% ASND ASCENDIS PHARMA A/S - ADR -- $392,837.50 2,857 BV9G6B8
0.62% BGNE BEIGENE LTD-ADR -- $381,969.00 2,100 BYYWPW6
0.57% JAZZ JAZZ PHARMACEUTICALS PLC -- $356,854.40 2,864 B4Q5ZN4
0.57% RVMD REVOLUTION MEDICINES INC -- $352,176.86 7,966 BL71K91
0.52% MDGL MADRIGAL PHARMACEUTICALS INC -- $323,755.74 1,034 BD59BS7
0.47% HALO HALOZYME THERAPEUTICS INC -- $290,127.64 6,028 2975098
0.43% BPMC BLUEPRINT MEDICINES CORP -- $268,915.20 3,008 BWY52P3
0.43% IONS IONIS PHARMACEUTICALS INC -- $268,606.80 7,480 BDJ0LS6
0.43% CYTK CYTOKINETICS INC -- $264,695.04 5,589 BBBSBJ5
0.41% -- TEMPUS AI INC COMMON STOCK USD 0.0001 -- $253,566.40 7,220 --
0.40% BBIO BRIDGEBIO PHARMA INC -- $250,566.48 8,952 BK1KWG8
0.40% NUVL NUVALENT INC-A -- $249,492.10 3,107 BMVBZD3
0.37% CRNX CRINETICS PHARMACEUTICALS IN -- $227,725.20 4,392 BDD19F8
0.36% ALKS ALKERMES PLC -- $226,500.75 7,665 B3P6D26
0.35% KRYS KRYSTAL BIOTECH INC -- $216,952.98 1,362 BD6JX35
0.33% ACLX ARCELLX INC -- $202,523.88 2,561 BPCJ1Q2
0.32% AXSM AXSOME THERAPEUTICS INC -- $198,976.50 2,295 BYZR4X4
0.32% SRRK SCHOLAR ROCK HOLDING CORP -- $197,580.24 4,444 BFZQ0L8
0.31% ADMA ADMA BIOLOGICS INC -- $195,370.20 11,196 B9NSBM2
0.31% APLS APELLIS PHARMACEUTICALS INC -- $192,550.56 5,892 BYTQ6X1
0.31% RARE ULTRAGENYX PHARMACEUTICAL IN -- $189,962.50 4,375 BJ62Z18
0.29% GH GUARDANT HEALTH INC -- $178,104.44 5,851 BFXC911
0.27% IMVT IMMUNOVANT INC -- $170,303.46 6,954 BJRFSB7
0.27% RNA AVIDITY BIOSCIENCES INC -- $170,181.72 5,652 BMWHPY1
0.27% PTCT PTC THERAPEUTICS INC -- $165,179.96 3,652 B17VCN9
0.26% VRNA VERONA PHARMA PLC - ADR -- $161,849.76 3,504 BYWPZK5
0.26% CRSP CRISPR THERAPEUTICS AG -- $161,800.86 4,043 BDHF4K6
0.26% RYTM RHYTHM PHARMACEUTICALS INC -- $161,766.90 2,910 BF2YWG4
0.26% -- ALVOTECH SA COMMON STOCK USD 0.0001 -- $160,136.13 12,639 --
0.25% NVCR NOVOCURE LTD -- $157,306.80 5,124 BYSS4X4
0.24% VCYT VERACYTE INC -- $147,240.40 3,670 BFTWZY0
0.23% DNLI DENALI THERAPEUTICS INC -- $140,498.37 6,817 BD2B4V0
0.23% XENE XENON PHARMACEUTICALS INC -- $140,253.96 3,612 BRJ3GY4
0.22% MRUS MERUS NV -- $136,475.08 3,244 BZBY005
0.22% FOLD AMICUS THERAPEUTICS INC -- $136,283.76 14,152 B19FQ48
0.22% TWST TWIST BIOSCIENCE CORP -- $135,343.65 2,810 BGKG6G7
0.22% JANX JANUX THERAPEUTICS INC -- $134,492.60 2,486 BMFX8Y7
0.22% VCEL VERICEL CORP -- $134,094.87 2,339 BSBMN89
0.22% RXRX RECURSION PHARMACEUTICALS-A -- $133,633.37 18,083 BM9FJ13
0.22% ACAD ACADIA PHARMACEUTICALS INC -- $133,532.10 7,878 2713317
0.21% EWTX EDGEWISE THERAPEUTICS INC -- $128,870.16 4,484 BKY5JZ8
0.21% SWTX SPRINGWORKS THERAPEUTICS INC -- $128,097.40 3,524 BGMGM89
0.20% LEGN LEGEND BIOTECH CORP-ADR -- $125,703.81 3,869 BMX9K07
0.20% VERA VERA THERAPEUTICS INC -- $124,147.18 2,998 BL55460
0.20% KYMR KYMERA THERAPEUTICS INC -- $123,097.59 3,069 BMPRZV5
0.18% AMRX AMNEAL PHARMACEUTICALS INC -- $114,774.14 14,677 BFNF1D6
0.18% DYN DYNE THERAPEUTICS INC -- $114,354.12 4,821 BN15WD1
0.18% -- NEWAMSTERDAM PHARMA CO NV COMMON STOCK USD -- $113,137.50 4,375 --
0.18% ARWR ARROWHEAD PHARMACEUTICALS IN -- $111,750.24 5,894 BYQBFJ8
0.18% PTGX PROTAGONIST THERAPEUTICS INC -- $109,945.12 2,822 BDCBCD8
0.17% IOVA IOVANCE BIOTHERAPEUTICS INC -- $106,393.32 14,436 BF0DMK7
0.17% BEAM BEAM THERAPEUTICS INC -- $104,259.39 3,921 BK6L288
0.17% IDYA IDEAYA BIOSCIENCES INC -- $103,030.20 4,095 BK0VHF6
0.16% TARS TARSUS PHARMACEUTICALS INC -- $99,550.00 1,810 BMH5RL1
0.16% APGE APOGEE THERAPEUTICS INC -- $97,712.73 2,133 BM9HHL5
0.16% LGND LIGAND PHARMACEUTICALS -- $97,615.86 894 2501578
0.16% SUPN SUPERNUS PHARMACEUTICALS INC -- $97,300.06 2,617 B72ZBG4
0.16% CGON CG ONCOLOGY INC -- $96,218.12 3,203 BRBCSP4
0.15% GERN GERON CORP -- $95,920.55 28,633 2370381
0.15% MIRM MIRUM PHARMACEUTICALS INC -- $94,465.88 2,273 BJDX8Y8
0.15% AKRO AKERO THERAPEUTICS INC -- $93,394.50 3,306 BK7Y2V9
0.15% WVE WAVE LIFE SCIENCES LTD -- $93,215.40 7,226 BYZG9R0
0.15% HRMY HARMONY BIOSCIENCES HOLDINGS -- $92,408.40 2,702 BKSGZN7
0.15% IBRX IMMUNITYBIO INC -- $91,759.46 33,007 BNSP0B8
0.15% IRON DISC MEDICINE INC -- $90,409.20 1,410 BMGJZJ8
0.15% AGIO AGIOS PHARMACEUTICALS INC -- $90,246.80 2,702 BCBVTX1
0.14% MNKD MANNKIND CORP -- $88,885.06 13,033 BF081J4
0.14% NMRA NEUMORA THERAPEUTICS INC -- $86,708.49 7,653 BN4JN37
0.14% AMPH AMPHASTAR PHARMACEUTICALS IN -- $86,070.60 2,277 BNFWZS4
0.13% FTRE FORTREA HOLDINGS INC -- $82,260.64 4,249 BRXYZ57
0.13% GPCR STRUCTURE THERAPEUTICS INC -- $81,921.84 2,821 BQS9486
0.13% DVAX DYNAVAX TECHNOLOGIES CORP -- $80,925.00 6,225 BRJZSK0
0.13% XNCR XENCOR INC -- $80,521.35 3,315 BGCYWN8
0.13% -- INDIVIOR PLC COMMON STOCK USD 0.5 -- $79,950.04 6,458 --
0.13% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $79,293.50 5,545 BKX9VD3
0.12% BCRX BIOCRYST PHARMACEUTICALS INC -- $75,635.10 9,810 2100362
0.12% TXG 10X GENOMICS INC-CLASS A -- $73,942.12 5,068 BKS3RS7
0.12% CNTA CENTESSA PHARMACEUTICALS-ADR -- $71,596.80 4,224 BLB0YQ9
0.11% TVTX TRAVERE THERAPEUTICS INC -- $70,277.76 4,067 BLFGJD5
0.11% PRAX PRAXIS PRECISION MEDICINES I -- $67,914.00 882 BQ721R4
0.11% SYRE SPYRE THERAPEUTICS INC -- $65,802.60 2,780 BQBBDY8
0.11% ZLAB ZAI LAB LTD-ADR -- $65,726.70 2,470 BD9GVY0
0.10% NRIX NURIX THERAPEUTICS INC -- $64,152.27 3,357 BMVLGP2
0.10% NVAX NOVAVAX INC -- $62,911.44 7,598 BJDQXG4
0.10% OCUL OCULAR THERAPEUTIX INC -- $62,844.24 7,446 BNZB1X8
0.10% AUPH AURINIA PHARMACEUTICALS INC -- $62,385.20 6,781 BFWLC09
0.10% ARVN ARVINAS INC -- $61,864.00 3,256 BDZ30Q0
0.10% DAWN DAY ONE BIOPHARMACEUTICALS I -- $61,467.12 4,776 BLB0YH0
0.09% ARDX ARDELYX INC -- $58,445.78 11,218 BN89V40
0.09% NTLA INTELLIA THERAPEUTICS INC -- $57,755.25 4,825 BYZM6C2
0.09% HROW HARROW INC -- $56,548.00 1,688 BHNDW86
0.09% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $54,741.68 1,876 BLCD809
0.09% ANIP ANI PHARMACEUTICALS INC -- $54,137.95 995 BCDWBX6
0.08% INVA INNOVIVA INC -- $52,053.30 2,966 BDDXF67
0.08% ELVN ENLIVEN THERAPEUTICS INC -- $51,786.55 2,315 BMFD115
0.08% SNDX SYNDAX PHARMACEUTICALS INC -- $51,629.11 4,043 BN7Q7R7
0.08% RCKT ROCKET PHARMACEUTICALS INC -- $50,724.75 4,317 BDFKQ07
0.08% SPRY ARS PHARMACEUTICALS INC -- $49,666.37 4,603 BMCR7V2
0.08% VIR VIR BIOTECHNOLOGY INC -- $48,694.20 6,523 BK4PZ38
0.08% AVXL ANAVEX LIFE SCIENCES CORP -- $48,621.65 4,015 BYTYP72
0.08% AVDL AVADEL PHARMACEUTICALS -- $48,071.21 4,563 BDGMC59
0.08% ZYME ZYMEWORKS INC -- $47,328.00 3,264 BPCQZY9
0.07% REPL REPLIMUNE GROUP INC -- $44,675.44 3,644 BDDVW37
0.07% COLL COLLEGIUM PHARMACEUTICAL INC -- $44,421.86 1,526 BX7RSN3
0.07% GRFS GRIFOLS SA-ADR -- $44,201.70 5,778 B8K7T65
0.07% ADPT ADAPTIVE BIOTECHNOLOGIES -- $43,967.10 6,990 BJ5FZ74
0.07% ETNB 89BIO INC -- $43,899.48 5,571 BK1K484
0.07% AVBP ARRIVENT BIOPHARMA INC -- $43,534.22 1,597 BMGTLY5
0.07% PCRX PACIRA BIOSCIENCES INC -- $42,954.90 2,186 B3X26D8
0.07% ABCL ABCELLERA BIOLOGICS INC -- $41,830.10 13,990 BL53SR3
0.07% GMAB GENMAB A/S -SP ADR -- $41,724.70 1,985 BBC9WC7
0.07% LENZ LENZ THERAPEUTICS INC -- $40,809.96 1,303 BQV0J03
0.07% COGT COGENT BIOSCIENCES INC -- $40,495.68 5,232 BLR6XK8
0.07% QURE UNIQURE NV -- $40,407.50 2,309 BJFSR88
0.06% KNSA KINIKSA PHARMACEUTICALS INTE -- $39,419.70 1,970 BRXB0C0
0.06% PLRX PLIANT THERAPEUTICS INC -- $39,093.48 2,883 BMDWW66
0.06% PRTA PROTHENA CORP PLC -- $38,576.72 2,548 B91XRN2
0.06% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $36,949.00 6,718 BMCWKZ2
0.06% CSTL CASTLE BIOSCIENCES INC -- $35,630.24 1,328 BKLCWZ3
0.06% RLAY RELAY THERAPEUTICS INC -- $34,570.44 7,929 BN2R582
0.05% ERAS ERASCA INC -- $34,018.22 13,393 BNLYBF3
0.05% IRWD IRONWOOD PHARMACEUTICALS INC -- $33,735.45 7,581 B3MZ6K5
0.05% TYRA TYRA BIOSCIENCES INC -- $33,725.79 2,397 BMVNDH9
0.05% CVAC CUREVAC NV -- $33,687.59 10,627 BN4RD42
0.05% HUMA HUMACYTE INC -- $33,522.50 6,095 BMYTJP4
0.05% EOLS EVOLUS INC -- $33,247.82 2,998 BDRJH21
0.05% CGEM CULLINAN THERAPEUTICS INC -- $33,151.16 2,758 BM90J52
0.05% RAPP RAPPORT THERAPEUTICS INC -- $32,959.96 1,732 BR3T9B6
0.05% -- TECTONIC THERAPEUTIC INC COMMON STOCK USD 0.0001 -- $32,826.94 698 --
0.05% OMER OMEROS CORP -- $32,049.92 2,744 B4NB858
0.05% KURA KURA ONCOLOGY INC -- $31,931.61 3,683 BYZD465
0.05% -- ORUKA THERAPEUTICS INC COMMON STOCK USD 0.001 -- $31,518.58 1,658 --
0.05% KROS KEROS THERAPEUTICS INC -- $31,493.56 1,918 BM7V485
0.05% GRAL GRAIL INC -- $31,203.20 1,592 BSLSSX7
0.05% TRDA ENTRADA THERAPEUTICS INC -- $30,850.52 1,772 BP81RK8
0.05% CRGX CARGO THERAPEUTICS INC -- $30,811.06 2,179 BQHN2F2
0.05% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $30,307.65 2,083 BKDQKM6
0.05% MLYS MINERALYS THERAPEUTICS INC -- $30,306.48 2,364 BP9N0G0
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $28,816.17 8,977 BZ0QMB7
0.04% STOK STOKE THERAPEUTICS INC -- $27,760.60 2,510 BJQ05Z6
0.04% ORIC ORIC PHARMACEUTICALS INC -- $27,579.75 3,343 BKVDFF7
0.04% -- MESOBLAST LTD ADR USD -- $26,557.95 1,515 --
0.04% PHAT PHATHOM PHARMACEUTICALS INC -- $26,495.02 3,239 BJLKVS6
0.04% ANNX ANNEXON INC -- $26,199.12 5,048 BMVV9R5
0.04% ALT ALTIMMUNE INC -- $25,832.56 3,368 BFY7DC4
0.04% SVRA SAVARA INC -- $25,609.50 8,130 BYXGN81
0.04% TRML TOURMALINE BIO INC -- $25,126.20 1,215 BQ80NC6
0.04% ATXS ASTRIA THERAPEUTICS INC -- $24,457.95 2,673 BMYRFN8
0.04% XERS XERIS BIOPHARMA HOLDINGS INC -- $24,215.80 7,060 BLR7H87
0.04% VERV VERVE THERAPEUTICS INC -- $24,134.18 4,009 BNKGXX2
0.04% PACB PACIFIC BIOSCIENCES OF CALIF -- $24,126.06 12,971 B4N8MH9
0.04% RNAC CARTESIAN THERAPEUTICS INC -- $23,827.16 1,204 BQB9HM8
0.04% MNMD MIND MEDICINE MINDMED INC -- $23,755.32 3,473 BPQYY97
0.04% CRMD CORMEDIX INC -- $23,603.75 2,875 BJ0LT31
0.04% EYPT EYEPOINT PHARMACEUTICALS INC -- $23,529.60 3,268 BMGS7L1
0.04% TERN TERNS PHARMACEUTICALS INC -- $23,206.94 4,022 BMDJ0C9
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $22,989.42 3,702 BFYQFJ2
0.04% TBPH THERAVANCE BIOPHARMA INC -- $22,344.70 2,330 BMNDK09
0.04% TKNO ALPHA TEKNOVA INC -- $22,051.98 2,526 BP7L561
0.04% THRD THIRD HARMONIC BIO INC -- $21,905.10 2,135 BNNPQY8
0.04% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $21,836.66 1,283 BKC9SX3
0.04% ALLO ALLOGENE THERAPEUTICS INC -- $21,748.89 9,931 BFZNYB7
0.03% URGN UROGEN PHARMA LTD -- $21,498.48 1,998 BZ7PJQ1
0.03% AUTL AUTOLUS THERAPEUTICS PLC -- $21,375.08 9,458 BFMLGR4
0.03% ESPR ESPERION THERAPEUTICS INC -- $21,281.52 9,334 BBNBTD2
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $21,226.70 2,530 BLFBZ32
0.03% HCM HUTCHMED CHINA-ADR -- $20,962.63 1,469 BYXV9H7
0.03% MXCT MAXCYTE INC -- $20,637.61 4,997 BKMQF66
0.03% OABI OMNIAB INC -- $20,581.47 5,733 BN13S71
0.03% GLUE MONTE ROSA THERAPEUTICS INC -- $20,537.54 2,909 BP7KZP7
0.03% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $20,313.25 965 BL95N25
0.03% SIGA SIGA TECHNOLOGIES INC -- $20,049.33 3,381 2107437
0.03% AURA AURA BIOSCIENCES INC -- $19,700.45 2,365 BP81R42
0.03% KALV KALVISTA PHARMACEUTICALS INC -- $19,687.24 2,308 BD06CS0
0.03% PSNL PERSONALIS INC -- $19,646.89 3,347 BJQ0608
0.03% CDXS CODEXIS INC -- $19,231.46 3,854 B5LL2C2
0.03% ANAB ANAPTYSBIO INC -- $18,777.60 1,440 BDRW1L7
0.03% GLPG GALAPAGOS NV-SPON ADR -- $18,072.60 662 B292NQ7
0.03% ALMS ALUMIS INC -- $18,038.28 2,238 BPLQG36
0.03% PRME PRIME MEDICINE INC -- $18,020.60 6,214 BPBJFM7
0.03% RGNX REGENXBIO INC -- $17,398.68 2,348 BZ0G875
0.03% SANA SANA BIOTECHNOLOGY INC -- $17,025.75 10,575 BMFJJ97
0.03% TSHA TAYSHA GENE THERAPIES INC -- $16,990.75 9,709 BNC1BX1
0.03% YMAB Y-MABS THERAPEUTICS INC -- $16,976.00 2,122 BG31GH0
0.03% DSGN DESIGN THERAPEUTICS INC -- $16,762.50 2,682 BMFK3H6
0.03% OLMA OLEMA PHARMACEUTICALS INC -- $16,697.25 2,715 BMZ4LN0
0.03% NGNE NEUROGENE INC -- $16,147.91 703 BS2F741
0.03% SAGE SAGE THERAPEUTICS INC -- $16,060.46 2,899 BP4GNK9
0.03% TNGX TANGO THERAPEUTICS INC -- $15,877.68 5,089 BP2P6L0
0.03% CRVS CORVUS PHARMACEUTICALS INC -- $15,859.24 3,044 BYP80F1
0.03% -- SILENCE THERAPEUTICS PLC ADR USD 0.05 -- $15,804.60 2,226 --
0.03% TRVI TREVI THERAPEUTICS INC -- $15,538.53 3,639 BJH9ZN0
0.02% SLRN ACELYRIN INC -- $15,440.75 4,751 BQPF874
0.02% RVNC REVANCE THERAPEUTICS INC -- $15,229.62 4,977 BJFSR99
0.02% AQST AQUESTIVE THERAPEUTICS INC -- $15,199.36 4,318 BYVQJ96
0.02% ABSI ABSCI CORP -- $15,068.80 5,440 BN94K69
0.02% VYGR VOYAGER THERAPEUTICS INC -- $14,855.12 2,588 BY7RB53
0.02% RIGL RIGEL PHARMACEUTICALS INC -- $13,777.50 835 BQD3J33
0.02% AVIR ATEA PHARMACEUTICALS INC -- $13,326.66 4,002 BLN9Z50
0.02% VNDA VANDA PHARMACEUTICALS INC -- $13,285.22 2,762 B12W3P6
0.02% LXRX LEXICON PHARMACEUTICALS INC -- $13,242.15 17,122 BWFZX59
0.02% ACIU AC IMMUNE SA -- $12,787.32 4,684 BZC0D70
0.02% FHTX FOGHORN THERAPEUTICS INC -- $12,686.24 2,632 BMF7DT9
0.02% CCCC C4 THERAPEUTICS INC -- $12,673.76 3,344 BKX9NQ0
0.02% ITOS ITEOS THERAPEUTICS INC -- $12,663.60 1,730 BMWXFT4
0.02% AMLX AMYLYX PHARMACEUTICALS INC -- $12,569.76 3,248 BPCK358
0.02% ARTV ARTIVA BIOTHERAPEUTICS INC -- $12,257.28 1,152 BMF1LJ7
0.02% FDMT 4D MOLECULAR THERAPEUTICS IN -- $12,137.85 2,187 BKLXFX5
0.02% LRMR LARIMAR THERAPEUTICS INC -- $11,967.12 3,022 BMXNGZ6
0.02% LXEO LEXEO THERAPEUTICS INC -- $10,732.74 1,583 BQ6C357
0.02% INBX INHIBRX BIOSCIENCES INC -- $10,311.87 687 BNSP8K3
0.02% IGMS IGM BIOSCIENCES INC -- $10,274.81 1,613 BKS3SM8
0.02% PGEN PRECIGEN INC -- $10,074.51 13,871 BKM5C84
0.02% CMPS COMPASS PATHWAYS PLC -- $9,611.91 2,409 BMC3HS7
0.02% MGNX MACROGENICS INC -- $9,606.02 2,974 BFDV8K0
0.01% INZY INOZYME PHARMA INC -- $8,885.56 3,043 BMVLGY1
0.01% FATE FATE THERAPEUTICS INC -- $8,777.72 5,452 BCZS820
0.01% MRSN MERSANA THERAPEUTICS INC -- $8,775.00 5,850 BF3NP05
0.01% ACRV ACRIVON THERAPEUTICS INC -- $8,732.00 1,475 BP2TPK4
0.01% LYEL LYELL IMMUNOPHARMA INC -- $8,595.60 13,224 BN6MB18
0.01% TVGN TEVOGEN BIO HOLDINGS INC -- $8,540.76 8,292 BPG5P75
0.01% AMRN AMARIN CORP PLC -ADR -- $8,493.18 18,958 2301938
0.01% ALEC ALECTOR INC -- $8,259.20 4,640 BJ4LDC4
0.01% KYTX KYVERNA THERAPEUTICS INC -- $8,159.55 2,045 BSMLR16
0.01% SCPH SCPHARMACEUTICALS INC -- $8,101.98 2,369 BYX2Z16
0.01% NKTX NKARTA INC -- $8,056.63 3,343 BK80YJ8
0.01% SLDB SOLID BIOSCIENCES INC -- $8,017.84 1,891 BQHN6C7
0.01% TSVT 2SEVENTY BIO INC -- $7,448.10 2,442 BMTXV88
0.01% STRO SUTRO BIOPHARMA INC -- $7,384.23 3,907 BF12XC2
0.01% TCRX TSCAN THERAPEUTICS INC -- $7,117.56 2,326 BNLYBJ7
0.01% BMEA BIOMEA FUSION INC -- $6,860.00 1,715 BNKF6N0
0.01% CLYM CLIMB BIO INC -- $6,684.30 3,183 BMW5LX6
0.01% PEPG PEPGEN INC -- $6,048.56 1,543 BMTX3D7
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $6,034.04 1,004 B9L5200
0.01% OKUR ONKURE THERAPEUTICS INC-A -- $4,936.80 605 BT7KGT6
0.01% EDIT EDITAS MEDICINE INC -- $4,732.31 3,911 BZ8FPH3
0.01% APLT APPLIED THERAPEUTICS INC -- $4,702.54 5,511 BJL38Z1
0.01% PYXS PYXIS ONCOLOGY INC -- $4,475.85 2,815 BLBR8D5
-- QTTB Q32 BIO INC -- $1,942.08 578 BS2FKQ4
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
34.58% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 21,462,850 -- 4,927 --
32.79% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 20,356,382 -- 4,673 --
28.20% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 17,503,091 -- 4,018 --
9.27% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 5,754,501 -- 1,321 --
6.81% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 4,225,485 -- 970 --
6.67% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 4,142,718 -- 951 --
4.79% -- NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 2,975,264 -- 683 --
-- -- TREASURY BILL -- $9,893,093.10 10,000,000 BTBKBR5
-- -- NET OTHER ASSETS (LIABILITIES) -- $4,408,465.90 4,408,466 --

Index

as of 9/30/2024

  • Total Number of Companies214
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$7.59 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.